Human Olfactory Mucosa Stem Cells Delivery Using a Collagen Hydrogel: As a Potential Candidate for Bone Tissue Engineering.
Sara SimorghPeiman Brouki MilanMaryam SaadatmandZohreh BagherMazaher GholipourmalekabadiRafieh AlizadehAhmad HivechiZohreh ArabpourMasoud HamidiDelattre CedricPublished in: Materials (Basel, Switzerland) (2021)
For bone tissue engineering, stem cell-based therapy has become a promising option. Recently, cell transplantation supported by polymeric carriers has been increasingly evaluated. Herein, we encapsulated human olfactory ectomesenchymal stem cells (OE-MSC) in the collagen hydrogel system, and their osteogenic potential was assessed in vitro and in vivo conditions. Collagen type I was composed of four different concentrations of (4 mg/mL, 5 mg/mL, 6 mg/mL, 7 mg/mL). SDS-Page, FTIR, rheologic test, resazurin assay, live/dead assay, and SEM were used to characterize collagen hydrogels. OE-MSCs encapsulated in the optimum concentration of collagen hydrogel and transplanted in rat calvarial defects. The tissue samples were harvested after 4- and 8-weeks post-transplantation and assessed by optical imaging, micro CT, and H&E staining methods. The highest porosity and biocompatibility were confirmed in all scaffolds. The collagen hydrogel with 7 mg/mL concentration was presented as optimal mechanical properties close to the naïve bone. Furthermore, the same concentration illustrated high osteogenic differentiation confirmed by real-time PCR and alizarin red S methods. Bone healing has significantly occurred in defects treated with OE-MSCs encapsulated hydrogels in vivo. As a result, OE-MSCs with suitable carriers could be used as an appropriate cell source to address clinical bone complications.
Keyphrases
- tissue engineering
- stem cells
- mesenchymal stem cells
- cell therapy
- bone mineral density
- bone regeneration
- soft tissue
- endothelial cells
- bone loss
- umbilical cord
- high resolution
- single cell
- high throughput
- magnetic resonance imaging
- bone marrow
- drug delivery
- postmenopausal women
- computed tomography
- body composition
- induced pluripotent stem cells
- real time pcr
- risk assessment
- dual energy
- human health
- positron emission tomography
- mass spectrometry
- replacement therapy